The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...
The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching US$8.85 billion ...
The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.
Total revenue, driven primarily from sales of Illuccix® of $783.2 million, up by 56% 1 from $502.5 million in 2023, beating full year guidance 2. R&D investment of $194.6 million, in line with ...